Lactose (India)

42
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE058I01013
  • NSEID:
  • BSEID: 524202
INR
88.95
0.95 (1.08%)
BSENSE

Nov 20

BSE+NSE Vol: 3.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 40.28% vs 2.20% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 8.36% vs -10.80% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -16.67% vs 16.18% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 17.43% vs -23.95% in Mar 2025

Compare Profit and Loss Results of Lactose (India)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
163.00
23.00
140.00
608.70%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
163.00
23.00
140.00
608.70%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
0.00
6.00
0%
Raw Materials Consumed
87.00
0.00
87.00
0%
Power & Fuel Cost
11.00
9.00
2.00
22.22%
Employee Cost
14.00
10.00
4.00
40.00%
Operating Expenses
14.00
2.00
12.00
600.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
0.00
5.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
2.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
144.00
29.00
115.00
396.55%
Operating Profit (PBDIT) excl Other Income
18.00
-5.00
23.00
460.00%
Other Income
1.00
2.00
-1.00
-50.00%
Operating Profit (PBDIT)
19.00
-3.00
22.00
733.33%
Interest
5.00
7.00
-2.00
-28.57%
Profit before Depriciation and Tax
14.00
-10.00
24.00
240.00%
Depreciation
5.00
6.00
-1.00
-16.67%
Profit Before Taxation & Exceptional Items
8.00
-16.00
24.00
150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
8.00
-16.00
24.00
150.00%
Provision for Tax
2.00
0.00
2.00
0%
Profit After Tax
6.00
-16.00
22.00
137.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
25.00
-297.00
322.00
108.42%
Profit Available for appropriations
31.00
-314.00
345.00
109.87%
Appropriations
31.00
-314.00
345.00
109.87%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.82
-7.85
12.67
161.40%
Profit And Loss - Net Sales
Net Sales 163.29 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 40.28% vs 2.20% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.38 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.36% vs -10.80% in Mar 2025

Profit And Loss - Interest
Interest 5.09 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -16.67% vs 16.18% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 6.06 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.43% vs -23.95% in Mar 2025